Work

Optimizing Informed Consent—A Call to Action

Year: 2025

Type: article

Abstract: This Viewpoint discusses the US Food and Drug Administration’s proposal for a collaborative approach toward clarifying the informed consent process for potential clinical trial participants.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2025.0824

Authors: Nancy E. Kass, Ann Meeker-O’Connell, Stephanie R. Morain, Matthew A. Crane

Institutions: Johns Hopkins University, Johns Hopkins Berman Institute of Bioethics, United States Food and Drug Administration, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000

OpenAlex ID: W4410019800

FWCI: 4.236

Cites: 3

Cited by: 5

Related to: 10